---
title: "Moclobemide - Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db01171-mesh-d003866-1.html
toc: false 
---


Path ID: `DB01171_MESH_D003866_1`
{% include image.html url="images/db01171-mesh-d003866-1.png" file="db01171-mesh-d003866-1.png" alt="db01171-mesh-d003866-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D020912">MESH:D020912 </a> | Moclobemide | Drug |
| <a href="https://identifiers.org/UniProt:P21397">UniProt:P21397 </a> | Amine oxidase [flavin-containing] A | Protein |
| <a href="https://identifiers.org/GO:0042402">GO:0042402 </a> | Cellular biogenic amine catabolic process | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Norepinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D012701">MESH:D012701 </a> | Serotonin | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0099153">GO:0099153 </a> | Synaptic transmission, serotonergic | BiologicalProcess |
| <a href="https://identifiers.org/GO:0099155">GO:0099155 </a> | Synaptic transmission, noradrenergic | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D003866">MESH:D003866 </a> | Depressive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Moclobemide | NEGATIVELY REGULATES | Amine Oxidase [Flavin-Containing] A |
| Amine Oxidase [Flavin-Containing] A | POSITIVELY REGULATES | Cellular Biogenic Amine Catabolic Process |
| Cellular Biogenic Amine Catabolic Process | DECREASES ABUNDANCE OF | Serotonin |
| Cellular Biogenic Amine Catabolic Process | DECREASES ABUNDANCE OF | Norepinephrine |
| Serotonin | POSITIVELY CORRELATED WITH | Synaptic Transmission, Serotonergic |
| Norepinephrine | POSITIVELY CORRELATED WITH | Synaptic Transmission, Noradrenergic |
| Synaptic Transmission, Serotonergic | DISRUPTED BY | Depressive Disorder |
| Synaptic Transmission, Noradrenergic | DISRUPTED BY | Depressive Disorder |
|---------|-----------|---------|

Comment: It is not approved for use in the United States, but is approved in other Western countries such as Canada, the UK and Australia.

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/26104056/](https://pubmed.ncbi.nlm.nih.gov/26104056/)
  - [https://www.ncbi.nlm.nih.gov/books/NBK539848/](https://www.ncbi.nlm.nih.gov/books/NBK539848/)
  - [https://pubmed.ncbi.nlm.nih.gov/12369606/](https://pubmed.ncbi.nlm.nih.gov/12369606/)
  - [https://go.drugbank.com/drugs/DB01171](https://go.drugbank.com/drugs/DB01171)
